Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study

Jinru Zhang,Juping Chen,Jia Li,Jian Li,Hong Miao,Xiangyang Zhu,Meng Meng,Yang Han,Jing Chen,Xiaoyu Cheng,Kangping Xiong,Hong Jin,Weifeng Luo,Chengjie Mao,Chunfeng Liu
DOI: https://doi.org/10.1097/cm9.0000000000002308
IF: 6.133
2022-10-05
Chinese Medical Journal
Abstract:To the Editor : Parkinson's disease (PD) is the second most common neurodegenerative disorder, and sleep disturbance is a major disabling non-motor symptom. [1] Excessive daytime sleepiness (EDS) is defined as inappropriate and undesirable sleepiness during waking hours, which may occur during activities such as talking or driving. In PD patients, EDS increased the risk of accidents and resulted in a poor quality of life. [2]
medicine, general & internal
What problem does this paper attempt to address?